Analyst Price Target is $22.57
▲ +26.66% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Avadel Pharmaceuticals in the last 3 months. The average price target is $22.57, with a high forecast of $29.00 and a low forecast of $16.00. The average price target represents a 26.66% upside from the last price of $17.82.
Current Consensus is
Buy
The current consensus among 6 polled investment analysts is to buy stock in Avadel Pharmaceuticals. This Buy consensus rating has held steady for over two years.